Loading...
Aroa Biosurgery Limited
ARX.AX•ASX
Healthcare
Medical - Devices
A$0.61
A$-0.03(-4.69%)
Aroa Biosurgery Limited (ARX.AX) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Aroa Biosurgery Limited (ARX.AX), covering cash flow, earnings, and balance sheets.
Revenue Growth
6.83%
↑ 6.83%
Operating Income Growth
-2666.19%
↓ 2666.19%
Net Income Growth
-2529.82%
↓ 2529.82%
Operating Cash Flow Growth
-93.62%
↓ 93.62%
Operating Margin
-3.49%
↓ 3.49%
Gross Margin
85.74%
↑ 85.74%
Net Profit Margin
-4.52%
↓ 4.52%
ROE
-4.14%
↓ 4.14%
ROIC
-3.01%
↓ 3.006%
Aroa Biosurgery Limited (ARX.AX) Income Statement & Financial Overview
Explore comprehensive income reports for Aroa Biosurgery Limited ARX.AX, broken down by year and quarter.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $17.99M | $17.88M | $17.06M | $17.25M |
| Cost of Revenue | $2.38M | $2.36M | $2.31M | $2.33M |
| Gross Profit | $15.61M | $15.52M | $14.75M | $14.91M |
| Gross Profit Ratio | $0.87 | $0.87 | $0.86 | $0.86 |
| R&D Expenses | $2.46M | $2.45M | $1.86M | $1.88M |
| SG&A Expenses | $15.68M | $15.59M | $15.49M | $15.66M |
| Operating Expenses | $17.88M | $17.77M | $17.03M | $17.15M |
| Total Costs & Expenses | $20.25M | $20.13M | $19.34M | $19.49M |
| Interest Income | $0.00 | $0.00 | $774163.00 | $265212.00 |
| Interest Expense | $0.00 | $0.00 | $233271.00 | $0.00 |
| Depreciation & Amortization | $774377.00 | $769646.00 | $781476.00 | $790073.00 |
| EBITDA | -$1.49M | -$1.48M | -$1.50M | -$1.52M |
| EBITDA Ratio | -$0.08 | -$0.08 | -$0.09 | -$0.09 |
| Operating Income | -$2.26M | -$2.25M | -$2.28M | -$2.31M |
| Operating Income Ratio | -$0.13 | -$0.13 | -$0.13 | -$0.13 |
| Other Income/Expenses (Net) | $928517.00 | $922844.00 | $326532.00 | $330124.00 |
| Income Before Tax | -$1.33M | -$1.33M | -$1.95M | -$1.98M |
| Income Before Tax Ratio | -$0.07 | -$0.07 | -$0.11 | -$0.11 |
| Income Tax Expense | $178720.00 | $177628.00 | $27516.00 | $27819.00 |
| Net Income | -$1.51M | -$1.50M | -$1.98M | -$2.004M |
| Net Income Ratio | -$0.08 | -$0.08 | -$0.12 | -$0.12 |
| EPS | -$0.004 | -$0.004 | -$0.006 | -$0.006 |
| Diluted EPS | -$0.004 | -$0.004 | -$0.006 | -$0.006 |
| Weighted Avg Shares Outstanding | $344.55M | $343.20M | $344.38M | $344.38M |
| Weighted Avg Shares Outstanding (Diluted) | $344.55M | $344.55M | $344.38M | $344.38M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan